Alan R. Boobis

发表

IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans

Alan R. Boobis, John E. Doe, Barbara Heinrich-Hirsch, 2008, Critical reviews in toxicology.

The role of hazard- and risk-based approaches in ensuring food safety

Maarten Nauta, Alan R. Boobis, Andrew Cockburn, 2015 .

52OMICS research adds substantially to the safety assessment of chemicals: The case against

Alan R. Boobis, 2006 .

Systems Toxicology: From Basic Research to Risk Assessment

Manuel C. Peitsch, Alan R. Boobis, Julia Hoeng, 2014, Chemical research in toxicology.

In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15.

Panos Macheras, Alan R. Boobis, Pierre Kremers, 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In vitro prediction of gastrointestinal absorption and bioavailability: an experts' meeting report

Alan R. Boobis, Ursula Gundert-Remy, Olavi Pelkonen, 2001, European Journal of Clinical Pharmacology.

The use of mode of action information in risk assessment: Quantitative key events/dose-response framework for modeling the dose-response for key events

Alan R. Boobis, Ted W. Simon, S. Stoney Simons, 2014, Critical reviews in toxicology.

Re: Guyton, Kathryn Z., Barone, Stanley, Jr., Brown, Rebecca C., Euling, Susan Y., Jinot, Jennifer, Makris, Susan (2008). Mode of Action Frameworks: A Critical Analysis. Journal of Toxicology and Environmental Health, Part B, 11(1): 16–31

Alan R. Boobis, Sharon Munn, Josef Schlatter, 2008, Journal of toxicology and environmental health. Part B, Critical reviews.

Thiazopyr and Thyroid Disruption: Case Study Within the Context of the 2006 IPCS Human Relevance Framework for Analysis of a Cancer Mode of Action

Alan R. Boobis, Sir Colin Berry, Douglas McGregor, 2006, Critical reviews in toxicology.

The Practical Applicability of Hepatocyte Cultures in Routine Testing

Alan R. Boobis, Vera Rogiers, Sandra Coecke, 1994 .

Using mode of action information to improve regulatory decision-making: An ECETOC/ILSI RF/HESI workshop overview

Alan R. Boobis, M. E. (Bette) Meek, Carolyn Vickers, 2011, Critical reviews in toxicology.

IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans

Alan R. Boobis, Carolyn Vickers, Vicki Dellarco, 2006 .

Chemical carcinogenicity revisited 3: Risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans.

Alan R. Boobis, Angelo Moretto, Rita S. Schoeny, 2019, Regulatory toxicology and pharmacology : RTP.

ACCELERATED PAPER: Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) at the Chinese hamster hprt locus

Alan R. Boobis, Nigel J. Gooderham, A. Boobis, 1996 .

Elucidation of Toxicity Pathways in Lung Epithelial Cells Induced by Silicon Dioxide Nanoparticles

Alan R. Boobis, Eugenia Valsami-Jones, John Cupitt, 2013, PloS one.

Development of new COSMOS oRepeatDose and non-cancer Threshold of Toxicological Concern (TTC) databases to support alternative testing methods for cosmetics related chemicals

Dimitar Hristozov, Detlef Keller, Andrew P. Worth, 2013 .

Meta-analysis of Studies of Alcohol and Breast Cancer with Consideration of the Methodological Issues

Alan R. Boobis, Simon G. Thompson, Susan Hodgson, 2006, Cancer Causes & Control.

Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement

Aldert Piersma, Alan R. Boobis, Martin van den Berg, 2016, Archives of Toxicology.